COGNICURRENT

Health insurance drug costs in South Korea nearly reached 28 trillion won in 2024, and the proportion of drug spending out of total health insurance expenses has slightly increased, standing higher than the OECD average.

SK Bioscience announced a partnership with global pharmaceutical company MSD to participate in the development project for an Ebola vaccine supported by CEPI.

Chabaitech and Novartis Korea have signed a strategic MoU to establish an Open Innovation Center aimed at supporting biotech startups.

Hyundai Bioscience is set to begin clinical trials for a universal antiviral treatment for dengue and similar diseases in Vietnam on March 30.

The Brazilian antitrust authority approved the acquisition of 4Bio by Profarma in a deal exceeding 600 million reais.

The expiration of the Ozempic patent will lead to a significant decrease in prices as generic versions from Indian pharmaceutical companies enter the market, but Argentine copies remain notably expensive.

Elisa Carrió commended Federico Sturzenegger for eliminating restrictions on obtaining pharmaceutical patents in Argentina.

Wiktor Janicki, President of the Innovative Pharmaceutical Employers' Association Infarma, emphasizes the need for Europe to increase investments in clinical research to maintain the pharmaceutical sector as a driver of the European economy.

Aneta Grzegorzewska discusses the aggressive strategy of Indian pharmaceutical companies entering the European market with generic products.

Global pharmaceutical companies are investing heavily in China's drug market to establish self-reliant supply chains, with a US$15 billion commitment announced during a recent UK delegation to Beijing.

Despite a paradigm shift towards combination therapies using new cancer drugs, challenges in insurance coverage persist due to regulatory obstacles and concerns about collusion among pharmaceutical companies.

The article discusses the importance of pharmaceutical security as a component of national security in Poland, emphasizing the challenges posed by supply chain interruptions due to global conflicts.

The pharmaceutical companies UNI-PHARMA and InterMed have been certified as Top Employers 2026 in Greece for the fourth consecutive year by the Top Employers Institute.

Lawyer Katarína Fedorová discusses the pharmaceutical business, the role of patient organizations in lobbying, and the need for critical evaluation of drug efficacy.

The increasing threat of antimicrobial resistance (AMR) is causing pharmaceutical companies to withdraw from antibiotic development, risking millions of lives if investments and policy actions do not improve.

The article discusses ongoing conflicts within the Argentine government, particularly focusing on the victory of Federico Sturzenegger in the pharmaceutical industry dispute.

The article discusses Argentina's former president Arturo Illia's attempts to regulate the contentious pharmaceutical patent market during his administration.

Nigeria's pharmaceutical sector voices concerns over potential medicine shortages due to the US-Iran conflict affecting drug imports and production materials.

Six individuals have been sentenced to prison for their roles in falsifying the injectable Yectafer, resulting in four fatalities and severe injuries to several others.

Concerns are increasing regarding the United States' growing reliance on Chinese pharmaceutical ingredients, as highlighted in a congressional hearing.

The president of the Mexican Association of Pharmaceutical Laboratories urged the government to prioritize local companies in public drug purchases to bolster the national pharmaceutical industry.

Argentina has lifted intellectual property restrictions on pharmaceuticals that had been in place since 2012, reflecting a long-standing conflict between domestic and foreign laboratories.

India is poised to significantly lower obesity rates with the upcoming expiration of the semaglutide patent, allowing local pharmaceutical companies to produce cheaper generic versions of Ozempic and Wegovy.

The Argentine government has deregulated pharmaceutical patents to align local practices with international standards, as announced by Minister Sturzenegger.

The Argentine government, under President Javier Milei, is working to regain legislative control while commemorating economist Adam Smith, amidst a political scandal.

This article lists various personnel changes in different organizations in South Korea.

The ongoing war in the Middle East is causing pharmaceutical companies to alter distribution routes to ensure that critical medicines reach Australia.

Chinese contract drug manufacturers face uncertainty in long-term revenue due to a US reshoring trend in the pharmaceutical industry.

Pharmacists in the UK are warning of potential medicine shortages due to Iran's blockade of the Strait of Hormuz, a key shipping route for pharmaceutical ingredients.

A pharmaceutical expert has raised alarms about the potential dangers of over-the-counter sleeping pills, particularly promethazine and diphenhydramine, citing research linking their use to increased mortality rates.

The Spanish pharmaceutical industry is facing potential supply chain disruptions due to geopolitical tensions, particularly concerning dependency on active pharmaceutical ingredients from other countries.

Anvisa has ordered the seizure of tirzepatide products produced irregularly by El Elyon de Manipulação Ltda in Brazil.

A new drug modification technique has been developed that significantly alters traditional pharmaceutical synthesis processes.

The CEO of Boehringer Ingelheim, Shashank Deshpande, expresses concerns over the slow approval process for new drugs in Germany compared to other countries, and emphasizes the need for closer collaboration with India in pharmaceutical research and development.

Grifols is experiencing increased bearish pressure from investors, marked by Kintbury Capital's significant short position, even as the company reports improved business results.

The conflict involving the U.S. and Israel against Iran is intensifying concerns over Brazil's reliance on imported pharmaceutical inputs.

The Korean pavilion has made its debut at the Bio China 2026 expo, reflecting increased participation from South Korea's pharmaceutical and biopharmaceutical sectors in the rapidly growing Chinese market.

The German Federal Court lowers the hurdles for obtaining information about vaccine side effects, making it easier for patients to file claims against pharmaceutical companies for COVID-19 vaccine-related damages.

Brazilian pharmaceutical EMS aims to introduce its generic version of Ozempic to the market by September, contingent on the approval from health agency Anvisa within the next 60 days.

Greek pharmacists demanded serious measures to address drug shortages during an event at the European Parliament, placing blame on companies for not meeting their obligations.

The founders of BioNTech, Ugur Sahin and Özlem Türeci, are leaving the company to create a new venture focused on next-generation mRNA medications.

BioNTech founders Uğur Şahin and Özlem Türeci will leave the company by the end of 2026 to start a new biotechnology firm focused on developing the next generation of mRNA-based drugs, while remaining shareholders in BioNTech.

BioNTech founders Uğur Şahin and Özlem Türeci will leave the company by the end of 2026 to establish a new biotechnology firm focused on mRNA-based medications while retaining a minority stake in BioNTech.

Andris Jegorovs resigns as a board member of Latvian pharmaceutical company Olpha amid declining revenue and profits.

A German court ruled in favor of patients suffering from vaccine side effects, easing access to information from pharmaceutical companies regarding potential risks.

Danish pharmaceutical giant Novo Nordisk has reached an agreement with the US online pharmacy Hims & Hers, dropping its lawsuit against the company regarding the sale of a copy of Wegovy.

Novo Nordisk has settled its lawsuit against the U.S. online pharmacy Hims & Hers, leading to a new collaboration allowing the pharmacy to sell Novo's medications.

On March 8, various companies in the pharmaceutical and bio sectors celebrated International Women’s Day with events promoting diversity and inclusiveness.

The next generation of drugs may emerge from algorithms rather than test tubes, as artificial intelligence increasingly transforms pharmaceutical laboratories.

Josip Meštrović, the Germany head of generics manufacturer Zentiva, expresses concerns about the potential impact of geopolitical tensions on Germany's pharmaceutical supply chain due to blocked shipping routes in the Hormuz Strait.